<?xml version="1.0" encoding="UTF-8"?>
<p>Thiopurines reduce the number and function of activated T cells
 <sup>
  <xref rid="CIT0032" ref-type="bibr">32</xref>
 </sup> and have been associated with an increased risk for viral infections.
 <sup>
  <xref rid="CIT0080" ref-type="bibr">80</xref>
 </sup> To date, there is insufficient evidence to conclude that thiopurines might actually increase the risk of SARS-CoV-2 infection. Because they still continue to exert their immunosuppressive effect for weeks after cessation,
 <sup>
  <xref rid="CIT0081" ref-type="bibr">81</xref>
 </sup> dose reduction and therapy discontinuation are not currently recommended.
 <sup>
  <xref rid="CIT0079" ref-type="bibr">79</xref>
 </sup>
</p>
